Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 92 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
|
Company BD Technologies and Innovation (RTP) | Activity: Research and Development | Company Description BD is a global medical technology company working to improve medical discovery, diagnostics and the delivery of care. The RTP site, established in 1972, is the North American hub of BD's global enterprise R&D network. | Location Research Triangle Park |
|
Company Propella Therapeutics Inc. | Activity: Research and Development | Company Description Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer. | Location Pittsboro |
 |
Company AccuNovo Biotechnologies Inc. | Activity: Research and Development | Company Description Accunovo is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. | Location Chapel Hill |
| |
Company Aktis Oncology | Activity: Research and Development | Company Description Aktis Oncology is developing targeted radiopharmaceuticals to treat solid tumor cancers. | Location Durham |
| |
Company AlphaVax Inc. | Activity: Research and Development | Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. | Location Research Triangle Park |
| |
Company AnelleO | Activity: Research and Development | Company Description AnelleO is developing a 3D-printed intravaginal ring that can be used for treating infertility and a wide range of other women's health conditions. | Location Chapel Hill |
| |
Company AntiXero LLC | Activity: Research and Development | Company Description AntiXero is developing a therapy for cancer-related dry mouth. | Location Raleigh |
| |
Company AstraZeneca (Durham-Winchester) | Activity: Research and Development | Company Description AstraZeneca's Winchester Place site in Durham specializes in research and development across the biopharmaceuticals, vaccines and immune therapies, rare disease and oncology business units. | Location Durham |
| |
Company Atrium Health Division of Therapeutic Research and Development | Activity: Research and Development | Company Description The Division of Therapeutic Research and Development at Atrium Health conducts clinical studies, patient-focused translational research and outcomes research. | Location Charlotte |
| |
Company Avicenna Biosciences Inc. | Activity: Research and Development | Company Description Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development. | Location Durham |
| |
Company Bantam Pharmaceutical LLC | Activity: Research and Development | Company Description Bantam Pharmaceutical develops small molecule cancer therapeutics for hematological malignancies and select solid tumors. | Location Durham |
| |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. | Location Huntersville |
| |
Company BioMedomics Inc. | Activity: Research and Development | Company Description BioMedomics develops and manufactures point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology. | Location Morrisville |
| |
Company Blue Ridge Institute for Medical Research | Activity: Research and Development | Company Description Blue Ridge Institute for Medical Research (BRIMR) researches small-molecule inhibitors of protein kinases and targeted cancer therapies. BRIMR also generates an annual ranking of NIH funding for U.S. medical schools and their departments. | Location Hendersonville |
| |
Company Cancer Advances Inc. | Activity: Research and Development | Company Description Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers. | Location Durham |
| |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill |
| |
Company CellSolutions LLC | Activity: Research and Development | Company Description CellSolutions develops liquid-based preparation and evaluation systems for cytology applications. The company's primary area of focus is women's health, including cervical cancer screening, precancer detection and evaluation of infectious disease. | Location Greensboro |
| |
Company Centaur Bio Inc. | Activity: Research and Development | Company Description Centaur Bio develops technology that facilitates precision drug delivery, which will potentially improve treatments for solid tumors and CNS disorders. | Location Charlotte |
| |
Company CivaTech Oncology Inc. | Activity: Research and Development | Company Description CivaTech Oncology has developed targeted implantable radiation devices to treat many cancer types. Products provide a targeted, customized radiation dose during a surgical resection procedure or in outpatient therapies to treat cancers. | Location Morrisville |
| |
Company Claradele Pharmaceuticals Inc. | Activity: Research and Development | Company Description Claradele Pharmaceuticals is developing an immunotherapy product to treat melanoma. | Location Winterville |
| |
Company Data Driven Bioscience Inc. | Activity: Research and Development | Company Description Data Driven Bioscience uses genomic tests, datasets and machine learning solutions to enable hospitals and pharmaceutical companies to diagnose cancer and personalize cancer treatment. | Location Durham |
| |
Company Datar Cancer Genetics | Activity: Research and Development | Company Description Datar Cancer Genetics develops blood-based diagnostics for early cancer detection and identifies personalized treatment strategies based on genomic and cellular analysis of a patient's cancer. | Location Morrisville |
| |
Company Deep Creek Pharma LLC | Activity: Research and Development | Company Description DeepCreek Pharma is commercializing CF10 fluoropyrimidine polymer technology to treat colon cancer. | Location Yadkinville |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company DotBio LLC | Activity: Research and Development | Company Description DotBio develops immuno-oncology therapies. | Location Weddington |
| |
Company Enfuego Therapeutics Inc. | Activity: Research and Development | Company Description Enfuego Therapeutics is developing novel RNA interference-(RNAi)-based and antisense oligo therapeutics. | Location Morrisville |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company ER Therapeutics LLC | Activity: Research and Development | Company Description ER Therapeutics is developing and commercializing therapeutics for cancer. | Location Chapel Hill |
| |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham |
| |
Company FastBack Bio LLC | Activity: Research and Development | Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. | Location Raleigh |
| |
Company Fennec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Fennec Pharmaceuticals develops a sodium thiosulfate formula for the prevention of ototoxicity from cisplatin in pediatric patients. | Location Research Triangle Park |
| |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh |
| |
Company Focal Medical Inc. | Activity: Research and Development | Company Description Focal Medical develops novel therapeutic products based on its local drug delivery technology platform. | Location Cary |
| |
Company Foundation Medicine Inc. | Activity: Research and Development | Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials. | Location Morrisville |
| |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park |
| |
Company GEM Tox Labs | Activity: Research and Development | Company Description GEM Tox Labs conducts research focused on the role of MicroRNA molecules in cancer. | Location Greenville |
| |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park |
| |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham |
| |
Company GeneType | Activity: Research and Development | Company Description GeneType develops genetic risk assessment tests to predict an individual's risk of developing chronic disease. | Location Charlotte |
| |
Company Gradient Medical Inc. | Activity: Research and Development | Company Description Gradient Medical develops interventional oncology therapies to treat primary and metastatic tumors using minimally invasive nanosecond pulsed electric fields. | Location Cary |
| |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham |
| |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park |
| |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park |
| |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh |
| |
Company Immunaeon (Winston-Salem) | Activity: Research and Development | Company Description Immunaeon provides services to isolate, analyze, and store healthy immune cells for patients for future immunotherapy treatments. | Location Winston-Salem |
| |
Company Immunolight LLC | Activity: Research and Development | Company Description Immunolight develops energy modulating technology to activate immunotherapeutics for the treatment of cancer. | Location Oak Island |
| |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park |
| |
Company Imugene Limited (Durham) | Activity: Research and Development | Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. | Location Durham |
| |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill |